(Q42548441)

2 November 2017

Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1): a clinical Phase II study (English)

1 reference

2 November 2017

1 reference

1 reference

5

Rübben H

1 reference

2 November 2017

Otto T

1

1 reference

2 November 2017

Bex A

series ordinal

2

1 reference

2 November 2017

Krege S

series ordinal

3

1 reference

2 November 2017

Walz PH

series ordinal

4

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

2 November 2017

1 reference

2 November 2017

80

1 reference

2 November 2017

465-470

1 reference

2 November 2017

3

1 reference

A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract

2 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

Regional Lymph Node Metastasis From Bladder Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

Usefulness and limitations of methotrexate, vinblastine, doxorubicin and cisplatin for the treatment of advanced urothelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970801%2980%3A3%3C465%3A%3AAID-CNCR14%3E3.0.CO%3B2-V

10.1002/(SICI)1097-0142(19970801)80:3<465::AID-CNCR14>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference